VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q56839637 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010728.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q56839637‏
024 ‎‡a 0000-0001-6925-0620‏ ‎‡2 orcid‏
024 ‎‡a 7404488275‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q56839637‏
100 0 ‎‡a John Mario González‏ ‎‡c researcher‏ ‎‡9 en‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a John Mario González‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's Astrocyte expression of a dominant-negative interferon-gamma receptor.‏
670 ‎‡a Author's Chagasic patients are able to respond against a viral antigen from influenza virus.‏
670 ‎‡a Author's Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.‏
670 ‎‡a Author's Differences in systemic and skin migrating-specific CD4 T cells in papular urticaria by flea bite‏
670 ‎‡a Author's Evaluation of IFN-gamma production by CD8+ T lymphocytes in response to the K1 peptide from KMP-11 protein in patients infected with Trypanosoma cruzi‏
670 ‎‡a Author's Expression of a dominant negative IFN-gammareceptor on mouse oligodendrocytes‏
670 ‎‡a Author's Helping flow cytometry communities grow‏
670 ‎‡a Author's HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT.‏
670 ‎‡a Author's Identification of HLA-A2 restricted CD8‏
670 ‎‡a Author's Identification of HLA-A2 restricted CD8(+) T-lymphocyte responses to Plasmodium vivax circumsporozoite protein in individuals naturally exposed to malaria‏
670 ‎‡a Author's Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein‏
670 ‎‡a Author's Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies‏
670 ‎‡a Author's Increased CD4+/CD8+ double-positive T cells in chronic Chagasic patients‏
670 ‎‡a Author's Infective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line.‏
670 ‎‡a Author's Inhibition of interferon-gamma signaling in oligodendroglia delays coronavirus clearance without altering demyelination‏
670 ‎‡a Author's Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys.‏
670 ‎‡a Author's Natural CD4+ T-cell responses against Trypanosoma cruzi KMP-11 protein in chronic chagasic patients‏
670 ‎‡a Author's Percentages of CD4+CD8+ Double-positive T Lymphocytes in the Peripheral Blood of Adults from a Blood Bank in Bogotá, Colombia‏
670 ‎‡a Author's Rabbit serum against K1 peptide, an immunogenic epitope of the Trypanosoma cruzi KMP-11, decreases parasite invasion to cells‏
670 ‎‡a Author's Seroprevalence of Antitransglutaminase and Antiendomysium Antibodies in Adult Colombian Blood Bank Donors‏
670 ‎‡a Author's Sulfocerebrosides upregulate liposome uptake in human astrocytes without inducing a proinflammatory response‏
670 ‎‡a Author's Synthetic polypeptides corresponding to the non-repeat regions from the circumsporozoite protein of Plasmodium falciparum: recognition by human T-cells and immunogenicity in owl monkeys‏
670 ‎‡a Author's Unstable, low-level transmission of malaria on the Colombian Pacific Coast‏
670 ‎‡a Author's Xenotransplantation of Human glioblastoma in Zebrafish larvae: in vivo imaging and proliferation assessment‏
909 ‎‡a (orcid) 0000000169250620‏ ‎‡9 1‏
909 ‎‡a (scopus) 7404488275‏ ‎‡9 1‏
919 ‎‡a astrocyteexpressionofadominantnegativeinterferongammareceptor‏ ‎‡A Astrocyte expression of a dominant-negative interferon-gamma receptor.‏ ‎‡9 1‏
919 ‎‡a seroprevalenceofantitransglutaminaseandantiendomysiumantibodiesinadultcolombianbloodbankdonors‏ ‎‡A Seroprevalence of Antitransglutaminase and Antiendomysium Antibodies in Adult Colombian Blood Bank Donors‏ ‎‡9 1‏
919 ‎‡a sulfocerebrosidesupregulateliposomeuptakeinhumanastrocyteswithoutinducingaproinflammatoryresponse‏ ‎‡A Sulfocerebrosides upregulate liposome uptake in human astrocytes without inducing a proinflammatory response‏ ‎‡9 1‏
919 ‎‡a infectivecapacityofcryptococcusneoformansandcryptococcusgattiiinahumanastrocytomacellline‏ ‎‡A Infective capacity of Cryptococcus neoformans and Cryptococcus gattii in a human astrocytoma cell line.‏ ‎‡9 1‏
919 ‎‡a mappingandcomparisonofthebcellepitopesrecognizedontheplasmodiumvivaxcircumsporozoiteproteinbyimmunecolombiansandimmunizedaotusmonkeys‏ ‎‡A Mapping and comparison of the B-cell epitopes recognized on the Plasmodium vivax circumsporozoite protein by immune Colombians and immunized Aotus monkeys.‏ ‎‡9 1‏
919 ‎‡a syntheticpolypeptidescorrespondingtothenonrepeatregionsfromthecircumsporozoiteproteinofplasmodiumfalciparumrecognitionbyhumantcellsandimmunogenicityinowlmonkeys‏ ‎‡A Synthetic polypeptides corresponding to the non-repeat regions from the circumsporozoite protein of Plasmodium falciparum: recognition by human T-cells and immunogenicity in owl monkeys‏ ‎‡9 1‏
919 ‎‡a identificationofhlaa2restrictedcd8‏ ‎‡A Identification of HLA-A2 restricted CD8‏ ‎‡9 1‏
919 ‎‡a helpingflowcytometrycommunitiesgrow‏ ‎‡A Helping flow cytometry communities grow‏ ‎‡9 1‏
919 ‎‡a identificationofhlaa2restrictedcd8+tlymphocyteresponsestoplasmodiumvivaxcircumsporozoiteproteininindividualsnaturallyexposedtomalaria‏ ‎‡A Identification of HLA-A2 restricted CD8(+) T-lymphocyte responses to Plasmodium vivax circumsporozoite protein in individuals naturally exposed to malaria‏ ‎‡9 1‏
919 ‎‡a hlaa0201restrictedcd8+tlymphocyteresponsestomalariaidentificationofnewplasmodiumfalciparumepitopesbyifngammaelispot‏ ‎‡A HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT.‏ ‎‡9 1‏
919 ‎‡a percentagesofcd4+cd8+doublepositivetlymphocytesintheperipheralbloodofadultsfromabloodbankinbogotacolombia‏ ‎‡A Percentages of CD4+CD8+ Double-positive T Lymphocytes in the Peripheral Blood of Adults from a Blood Bank in Bogotá, Colombia‏ ‎‡9 1‏
919 ‎‡a chagasicpatientsareabletorespondagainstaviralantigenfrominfluenzavirus‏ ‎‡A Chagasic patients are able to respond against a viral antigen from influenza virus.‏ ‎‡9 1‏
919 ‎‡a rabbitserumagainstk1peptideanimmunogenicepitopeofthetrypanosomacruzikmp11decreasesparasiteinvasiontocells‏ ‎‡A Rabbit serum against K1 peptide, an immunogenic epitope of the Trypanosoma cruzi KMP-11, decreases parasite invasion to cells‏ ‎‡9 1‏
919 ‎‡a immunologicalandstructuralcharacterizationofanepitopefromthetrypanosomacruzikmp11protein‏ ‎‡A Immunological and structural characterization of an epitope from the Trypanosoma cruzi KMP-11 protein‏ ‎‡9 1‏
919 ‎‡a immunologicalassaysforsarscov2ananalysisofavailablecommercialteststomeasureantigenandantibodies‏ ‎‡A Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies‏ ‎‡9 1‏
919 ‎‡a characterisingthekmp11andhsp70recombinantantigenshumoralimmuneresponseprofileinchagasicpatients‏ ‎‡A Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.‏ ‎‡9 1‏
919 ‎‡a expressionofadominantnegativeifngammareceptoronmouseoligodendrocytes‏ ‎‡A Expression of a dominant negative IFN-gammareceptor on mouse oligodendrocytes‏ ‎‡9 1‏
919 ‎‡a xenotransplantationofhumanglioblastomainzebrafishlarvaeinvivoimagingandproliferationassessment‏ ‎‡A Xenotransplantation of Human glioblastoma in Zebrafish larvae: in vivo imaging and proliferation assessment‏ ‎‡9 1‏
919 ‎‡a unstablelowleveltransmissionofmalariaonthecolombianpacificcoast‏ ‎‡A Unstable, low-level transmission of malaria on the Colombian Pacific Coast‏ ‎‡9 1‏
919 ‎‡a inhibitionofinterferongammasignalinginoligodendrogliadelayscoronavirusclearancewithoutalteringdemyelination‏ ‎‡A Inhibition of interferon-gamma signaling in oligodendroglia delays coronavirus clearance without altering demyelination‏ ‎‡9 1‏
919 ‎‡a differencesinsystemicandskinmigratingspecificcd4tcellsinpapularurticariabyfleabite‏ ‎‡A Differences in systemic and skin migrating-specific CD4 T cells in papular urticaria by flea bite‏ ‎‡9 1‏
919 ‎‡a evaluationofifngammaproductionbycd8+tlymphocytesinresponsetothek1peptidefromkmp11proteininpatientsinfectedwithtrypanosomacruzi‏ ‎‡A Evaluation of IFN-gamma production by CD8+ T lymphocytes in response to the K1 peptide from KMP-11 protein in patients infected with Trypanosoma cruzi‏ ‎‡9 1‏
919 ‎‡a naturalcd4+tcellresponsesagainsttrypanosomacruzikmp11proteininchronicchagasicpatients‏ ‎‡A Natural CD4+ T-cell responses against Trypanosoma cruzi KMP-11 protein in chronic chagasic patients‏ ‎‡9 1‏
919 ‎‡a increasedcd4+cd8+doublepositivetcellsinchronicchagasicpatients‏ ‎‡A Increased CD4+/CD8+ double-positive T cells in chronic Chagasic patients‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 BNF|13992614
996 ‎‡2 ISNI|0000000076143551
996 ‎‡2 NUKAT|n 2021025363
996 ‎‡2 NKC|jo2005267919
996 ‎‡2 CAOONL|ncf10064117
996 ‎‡2 ISNI|0000000048854487
996 ‎‡2 J9U|987007368401005171
996 ‎‡2 ISNI|0000000459280369
996 ‎‡2 B2Q|0001512567
996 ‎‡2 SUDOC|153147628
996 ‎‡2 ISNI|0000000454266963
996 ‎‡2 ISNI|0000000040691732
996 ‎‡2 BNE|XX931708
996 ‎‡2 NII|DA18461411
996 ‎‡2 NKC|mzk20231206531
996 ‎‡2 DNB|1029898723
996 ‎‡2 LC|n 2015187981
996 ‎‡2 DNB|123022614
996 ‎‡2 LC|no2006131162
996 ‎‡2 BNE|XX4986291
996 ‎‡2 LC|n 93054367
996 ‎‡2 LC|no2017148924
996 ‎‡2 LC|ns2019000832
996 ‎‡2 BNF|18123922
996 ‎‡2 DNB|1066880042
996 ‎‡2 LC|no2021154921
996 ‎‡2 SUDOC|146743490
996 ‎‡2 RERO|A023073595
996 ‎‡2 ISNI|0000000513606949
996 ‎‡2 SUDOC|280922590
996 ‎‡2 CAOONL|ncf10653251
996 ‎‡2 BNE|XX5221407
996 ‎‡2 ISNI|0000000080045348
996 ‎‡2 BIBSYS|10021580
996 ‎‡2 DNB|131914182X
996 ‎‡2 LC|n 2002134842
996 ‎‡2 ISNI|0000000445907749
996 ‎‡2 ISNI|000000003542826X
996 ‎‡2 PTBNP|117567
996 ‎‡2 SUDOC|267781164
996 ‎‡2 LC|no2015040186
996 ‎‡2 LC|no2014103214
996 ‎‡2 ISNI|0000000061572214
996 ‎‡2 DNB|1027596746
996 ‎‡2 DNB|105768838X
996 ‎‡2 SUDOC|238193330
996 ‎‡2 PTBNP|997438
996 ‎‡2 J9U|987007340889205171
996 ‎‡2 J9U|987007372077705171
996 ‎‡2 BLBNB|001512484
996 ‎‡2 ISNI|0000000118736233
996 ‎‡2 DNB|1199582786
996 ‎‡2 BNC|981058517781506706
996 ‎‡2 ISNI|0000000037908793
996 ‎‡2 SUDOC|262884828
996 ‎‡2 ISNI|0000000115653635
996 ‎‡2 BIBSYS|90400869
996 ‎‡2 LC|no2020094666
996 ‎‡2 PTBNP|1489402
996 ‎‡2 ISNI|0000000499942945
996 ‎‡2 DNB|140283390
996 ‎‡2 LC|no2018153481
996 ‎‡2 LC|no2024106745
996 ‎‡2 LC|ns2020000795
996 ‎‡2 LC|no2023029058
996 ‎‡2 RERO|A027281351
996 ‎‡2 PLWABN|9810562106605606
996 ‎‡2 SUDOC|242406785
996 ‎‡2 LC|n 2022000837
996 ‎‡2 BNCHL|10000000000000000859924
996 ‎‡2 ISNI|0000000079084198
996 ‎‡2 LC|no 98076918
996 ‎‡2 BNC|981058612834006706
996 ‎‡2 BNC|981058512650606706
996 ‎‡2 SUDOC|234281782
996 ‎‡2 ISNI|0000000117557479
996 ‎‡2 BNE|XX957695
996 ‎‡2 DNB|1284680479
996 ‎‡2 PTBNP|85525
996 ‎‡2 LC|n 2015040463
996 ‎‡2 ISNI|0000000105738571
996 ‎‡2 BNE|XX1251154
996 ‎‡2 DNB|1057373788
996 ‎‡2 ISNI|0000000062241572
996 ‎‡2 NKC|mzk2018979258
996 ‎‡2 ISNI|0000000091501943
996 ‎‡2 BNE|XX1161050
996 ‎‡2 RERO|A020197741
996 ‎‡2 BNF|16573041
996 ‎‡2 LC|no2005049303
996 ‎‡2 LC|no2023008145
996 ‎‡2 LC|n 2005056538
996 ‎‡2 ISNI|000000042906557X
996 ‎‡2 ISNI|0000000066388192
996 ‎‡2 DNB|1079278451
996 ‎‡2 LC|no2016079187
996 ‎‡2 DNB|1123521689
996 ‎‡2 BNCHL|10000000000000000134215
996 ‎‡2 DNB|140732977
996 ‎‡2 BNE|XX5551066
996 ‎‡2 LC|n 2016045831
996 ‎‡2 ISNI|0000000110313615
996 ‎‡2 NSK|000637285
996 ‎‡2 ISNI|0000000081301550
996 ‎‡2 BNCHL|10000000000000000815478
996 ‎‡2 BNCHL|10000000000000000837612
996 ‎‡2 LNB|LNC10-000245167
996 ‎‡2 LC|n 2015052754
996 ‎‡2 LC|no2015155548
996 ‎‡2 ISNI|000000045058469X
996 ‎‡2 LC|no2023014587
996 ‎‡2 LC|no2019015310
996 ‎‡2 LC|n 2010059740
996 ‎‡2 BNCHL|10000000000000000181918
996 ‎‡2 BNF|16207114
996 ‎‡2 BNE|XX5506631
996 ‎‡2 ISNI|0000000043188649
996 ‎‡2 ISNI|000000005946154X
996 ‎‡2 RERO|A011993276
996 ‎‡2 LC|n 2010050698
996 ‎‡2 DNB|1331513995
996 ‎‡2 ISNI|000000040939646X
996 ‎‡2 DNB|1337593907
996 ‎‡2 DNB|114832495X
996 ‎‡2 SUDOC|193252821
996 ‎‡2 LC|no2021079231
996 ‎‡2 ISNI|000000005976433X
996 ‎‡2 BLBNB|001476507
996 ‎‡2 LC|no2017087568
996 ‎‡2 LC|no2018083176
996 ‎‡2 ISNI|0000000070940242
996 ‎‡2 LC|n 2006169566
996 ‎‡2 CAOONL|ncf11896639
996 ‎‡2 NTA|407518371
996 ‎‡2 BNC|981058617604606706
996 ‎‡2 LC|no 96026916
996 ‎‡2 PLWABN|9812401464305606
996 ‎‡2 SUDOC|276299078
996 ‎‡2 SUDOC|258081414
996 ‎‡2 ISNI|0000000428296392
996 ‎‡2 NSK|000598839
996 ‎‡2 SUDOC|057289654
996 ‎‡2 LC|n 2019186779
996 ‎‡2 BNC|981058514905006706
996 ‎‡2 J9U|987010984321005171
996 ‎‡2 BNF|17725099
996 ‎‡2 LC|n 2009012062
996 ‎‡2 NTA|072639822
996 ‎‡2 ISNI|000000004471775X
996 ‎‡2 DNB|1114193631
996 ‎‡2 NUKAT|n 2012142435
996 ‎‡2 BNE|XX5858742
996 ‎‡2 LC|n 90611056
996 ‎‡2 DNB|1179422635
996 ‎‡2 LC|no 95054606
996 ‎‡2 BNE|XX1684381
996 ‎‡2 BNE|XX5351669
996 ‎‡2 SUDOC|179945556
996 ‎‡2 LC|n 2018250089
996 ‎‡2 LC|n 90601230
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏